Evgen Pharma's lead asset SFX-01 shows promise in enhancing radiation therapy

Evgen Pharma PLC (AIM:EVG) said its collaborative research with Sapienza University of Rome has confirmed the potential of lead asset SFX-01 to augment the...

Related Keywords

Helen Kuhlman ,Simona Camero ,Francesco Marampon ,Sapienza University Of Rome ,Evgen Pharma ,Department Of Radiotherapy ,Department Of Experimental Medicine ,Rare Cancers Congress ,Sapienza University ,